Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules

Roberta Piva1, Letizia Penolazzi, Margherita Zennaro

  • 1Department of Biochemistry and Molecular Biology, Section of Molecular Biology, Università degli Studi di Ferrara, Via Fossato di Mortara 74, 44100 Ferrara, Italy.

Insights

Two decoy oligonucleotides effectively induce apoptosis in human osteoclasts (OCs). This approach shows potential for clinical applications in skeletal health by targeting key cellular pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteoclasts (OCs) are crucial for bone remodeling and skeletal development.
  • Dysregulation of osteoclast activity is implicated in various skeletal diseases.
  • Targeting osteoclast apoptosis is a potential therapeutic strategy for bone disorders.

Purpose of the Study:

  • To investigate the effects of two novel transcription factor decoy oligonucleotides on human osteoclast apoptosis.
  • To determine the molecular mechanisms underlying the apoptotic response induced by these decoys.
  • To assess the in vivo efficacy of these oligonucleotides in inducing osteoclast apoptosis.

Main Methods:

  • Utilized transcription factor decoy oligonucleotides designed to inhibit nuclear factor kappa-B (NF-kappaB) and increase estrogen receptor (ER) alpha expression.
  • Assessed apoptosis in human osteoclasts (OCs) using specific assays.
  • Measured caspase 3 activity and interleukin 6 (IL-6) expression levels.
  • Evaluated the in vivo effects of the decoy oligonucleotides.

Main Results:

  • Both decoy oligonucleotides demonstrated potent induction of apoptosis in human osteoclasts.
  • Apoptosis induction was associated with increased caspase 3 activity.
  • A decrease in interleukin 6 (IL-6) expression was observed following decoy treatment.
  • Evidence suggests these oligonucleotides are active in vivo, inducing osteoclast apoptosis.

Conclusions:

  • Transcription factor decoy oligonucleotides targeting NF-kappaB and ER alpha are effective inducers of human osteoclast apoptosis.
  • This targeted induction of apoptosis presents a promising therapeutic approach for conditions involving osteoclast dysfunction.
  • The findings highlight the clinical potential of these decoy molecules for managing skeletal health.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.